Glioma angiogenesis and perfusion imaging: understanding the relationship between tumor blood volume and leakiness with increasing glioma grade R Jain, B Griffith, F Alotaibi, D Zagzag, H Fine, J Golfinos, L Schultz American Journal of Neuroradiology 36 (11), 2030-2035, 2015 | 42 | 2015 |
Multifaceted CXC chemokine receptor 4 (CXCR4) inhibition interferes with anti–vascular endothelial growth factor therapy–induced glioma dissemination JP Gagner, Y Sarfraz, V Ortenzi, FM Alotaibi, LA Chiriboga, AT Tayyib, ... The American journal of pathology 187 (9), 2080-2094, 2017 | 38 | 2017 |
A surgical framework for the management of incomplete axillary nerve injuries D Chi, AY Ha, F Alotaibi, S Pripotnev, BCM Patterson, W Fongsri, ... Journal of reconstructive microsurgery 39 (08), 616-626, 2023 | 2 | 2023 |
The Blood-Brain-Barrier in Brain Tumors S Shroff, R Jain, S Najjar, FM Alotaibi, D Zagzag The Blood-Brain Barrier in Health and Disease, Volume Two: Pathophysiology …, 2015 | 1 | 2015 |
Abstract A20: A novel CXCR4 antagonist interferes with antivascular endothelial growth factor therapy-induced glioma dissemination JP Gagner, Y Sarfraz, FM Alotaibi, V Ortenzi, AT Tayyib, LA Chiriboga, ... Cancer Research 75 (23_Supplement), A20-A20, 2015 | | 2015 |
A novel CXCR4 antagonist interferes with antivascular endothelial growth factor therapy-induced glioma dissemination JP Gagner, Y Sarfraz, FM Alotaibi, V Ortenzi, AT Tayyib, LA Chiriboga, ... CANCER RESEARCH 75, 2015 | | 2015 |
ET-51 COMBINED THERAPY WITH A NOVEL CXCR4 ANTAGONIST AND AN ANTI-VEGF ANTIBODY IMPAIRS THE GROWTH OF GLIOMAS Y Sarfraz, FM Alotaibi, V Ortenzi, AT Tayyib, GJ Douglas, E Chevalier, ... Neuro-oncology 16 (suppl_5), v90-v90, 2014 | | 2014 |